English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduPatients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are at significant risk for cardiovascular disease and stroke, according to new research from New York Eye and Ear Infirmary of Mount Sinai.
Tag: Icahn School of Medicine at Mount Sinai
Blacks Found Twice as Likely to Have Atherosclerosis as Hispanics in Young Adult Populations in Underserved Communities
A unique Mount Sinai study focused on a multi-ethnic, underserved community in New York City shows that young Black adults are twice as likely to have atherosclerosis as similarly situated young Hispanic adults.
Stress Testing Can Help Determine Which Patients Are Likely to Benefit From Heart Procedures to Improve Survival
Mount Sinai study can help guide proper treatment course for patients depending on heart function and severity of heart damage
Researchers Discover Mechanisms of Drug-Resistant Fungal Infection in Transplant Patient
Experts Encourage Rapid Genomic Screenings and Development of New Therapeutics for Drug-Resistant Pathogens to Address Emerging Global Health Concern
Immune Molecules From a Llama Could Provide Protection Against a Vast Array of SARS-like Viruses Including COVID-19, Researchers Say
Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses.
Study Finds Untreated Sleep Apnea May Increase Risk for Neurodegenerative Disease, PAP Therapies Crucial in Treating the Sleep Condition
Mount Sinai researchers have conducted one of the first studies to show the acute effect of obstructive sleep apnea on Alzheimer’s disease biomarkers, and the ability to even measure Alzheimer’s disease biomarkers from blood.
Specific Environmental Exposures may Help Predict Increased Risk of Death from Cardiovascular Disease
A new study from the Icahn School of Medicine at Mount Sinai quantifies the cardiovascular risk posed by exposure to specific environmental factors, showing, for example, that air pollution heightens the risk of heart disease mortality by 17 percent.
Mount Sinai Researchers Develop Machine Learning Model that Can Detect and Predict COVID-19 from Collected Data on Wearable Devices
Mount Sinai researchers have developed a machine learning algorithm that can determine if an individual has SARS-CoV-2 infections, the virus that causes COVID-19—with a high sensitivity and specificity—from the data collected by wearable devices.
Mount Sinai Researcher Receives Prestigious Award From the American Association of Indian Scientists in Cancer Research
Nina Bhardwaj, MD, PhD, Director of Immunotherapy at The Tisch Cancer Institute at Mount Sinai, has received the 2022 Lifetime Achievement in Cancer Research award from the American Association of Indian Scientists in Cancer Research (AAISCR).
Heart Failure Patients Unvaccinated Against COVID-19 Are Three Times More Likely to Die From It Than Boosted Heart Failure Patients
EMBARGOED UNTIL JUNE 9, 2022, 10AM EST (New York, NY – June 9, 2022) – Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus…
Advanced Radiotherapy Offers Safe, Effective Treatment for Patients with Early-Stage Liver Cancer, Study Finds
An advanced radiotherapy technique called radiation segmentectomy may be effective against very early to early-stage hepatocellular carcinoma (HCC), a type of liver cancer that cannot be treated surgically or thermally.
The Mount Sinai Hospital Recognized on Newsweek’s “America’s Best Maternity Hospitals 2022” List
The Mount Sinai Hospital has earned top honors on Newsweek’s list of “America’s Best Maternity Hospitals 2022” for providing high-quality maternity care from pregnancy through birth, as well as postpartum care to ensure the long-term health of both newborns and new mothers.
Mount Sinai Receives Landmark Gift from Royalty Pharma to Advance Health Equity
Marking a major advance in its efforts to achieve equity in the delivery of health care, the Icahn School of Medicine at Mount Sinai (Icahn Mount Sinai) announced today that its Institute for Health Equity Research (IHER) has received a landmark $20 million gift over five years from Royalty Pharma plc (Nasdaq: RPRX) and certain members of its management team.
Mount Sinai Ranked No. 5 on the 2022 DiversityInc Top Hospitals and Health Systems List
The Mount Sinai Health System was ranked No. 5 on DiversityInc’s Top Hospitals and Health Systems list for 2022.
Mount Sinai’s Brendan Carr, MD, MS, Receives Prestigious “Chair of the Year Award” from Emergency Medicine Residents’ Association
The Emergency Medicine Residents’ Association (EMRA) of the American College of Emergency Physicians has honored Brendan G. Carr, MD, MS, Chair of Emergency Medicine at the Icahn School of Medicine of Mount Sinai and Mount Sinai Health System, with the prestigious “2022 Chair of the Year Award.” He is the only department chair in the country to receive this distinction for 2022, recognizing his exceptional leadership.
Mount Sinai Cardiologist Develops New Risk Score to Help Predict Possible Contrast-Associated Kidney Injury After Percutaneous Coronary Intervention
Assessment can help stratify high-risk patients for monitoring before, during, and after procedures to improve outcomes
Novel Surgical Device Can Potentially Improve Outcomes of Coronary Bypass Grafting That Uses Leg Veins
(New York, NY – November 13, 2021) –A novel device called venous external support (VEST) may lead to increased longevity and durability of saphenous (leg) vein grafting during coronary artery bypass surgery, according to a new trial done in collaboration…
AMERICAN SOCIETY OF NEPHROLOGY ANNOUNCES THE BARBARA T. MURPHY ENDOWED LECTURESHIP
Today, the American Society of Nephrology (ASN) announced the Barbara T. Murphy Endowed Lectureship. Established by Verici Dx (LSE: VRCI), Renalytix (LSE RENX and Nasdaq RNLX), and the American Society of Transplantation (ATS), the new lectureship will honor Dr. Murphy’s legacy as a leader in transplant immunology and medicine by recognizing advances in kidney transplantation.
New Treatment Approach for Advanced Coronary Artery Disease Leads to Improved Outcomes
Study outlines better way to identify where stents are necessary
Renowned Physician-Scientist with Expertise in High-Risk Pregnancies Named System Chair of Obstetrics, Gynecology, and Reproductive Science at Mount Sinai Health System
Joanne L. Stone, MD, a leading physician-scientist in women’s health with special expertise in fetal imaging and caring for high-risk pregnancies, has been named the Chair of Obstetrics, Gynecology, and Reproductive Science for the Icahn School of Medicine at Mount Sinai and the Mount Sinai Health System. Dr. Stone currently serves as Director of the Maternal-Fetal Medicine and Fellowship program for the Mount Sinai Health System, Vice Chair for Diversity and Inclusion of the OB/GYN Department, and Immediate Past President of the Faculty Council.
Mount Sinai Educator and Diversity Champion Named to Modern Healthcare’s Top Diversity Leaders List
Ann-Gel S. Palermo, DrPH, MPH—recognized as an innovative champion for diversity, equity, and inclusion—has been named by Modern Healthcare as one of 2021’s Top Diversity Leaders
Shrinking Waveforms on Electrocardiograms Predict Worsening Health and Death of Hospitalized COVID-19 and Influenza Patients
Spotting changes in the heart’s electrical activity may prompt more-aggressive treatment and monitoring.
Mount Sinai Neurobiologist Selected as a Howard Hughes Medical Institute Investigator
The Howard Hughes Medical Institute (HHMI) has selected Ian Maze, PhD, Associate Professor of Neuroscience, and Pharmacological Sciences, at the Icahn School of Medicine at Mount Sinai, as an HHMI Investigator.
Mount Sinai Boards of Trustees Announce Updated Leadership Structure
The Mount Sinai Boards of Trustees today announced leadership updates that will position the Mount Sinai Health System for future challenges and opportunities.
Mount Sinai Researchers Use Wearable Devices to Identify Psychological Effects of Pandemic
Study links changes in heart rate variability with degree of resilience, as part of larger effort to understand and mitigate the effects of COVID-19 on health care workers
Mount Sinai’s Center for Psychedelic Psychotherapy and Trauma Research Receives $5 Million Grant From The Bob & Renee Parsons Foundation
Funds will support cutting-edge MDMA-assisted therapy for PTSD
Mount Sinai Health System Launches Comprehensive Mobile App for Patients
New features include upload for COVID-19 vaccination proof and hospital navigation
Mount Sinai Cardiologist Leads Effort to Outline Guidance for Management of Heart Failure Patients During COVID-19 Pandemic
New scientific statement aims to establish more streamlined care to improve outcomes in this high-risk group
Edoxaban May Be Effective Treatment for Atrial Fibrillation After Transcatheter Aortic Valve Replacement
Mount Sinai study is first to compare this anticoagulant with the standard of care in large randomized clinical trial
Mount Sinai Receives $2.9 Million to Study First-of-its-kind Brain Implant for Restoring Function in Paralyzed Patients
Department of Rehabilitation and Human Performance will lead Mount Sinai in national clinical trial
Mount Sinai Queens Earns Prestigious Thrombectomy-Capable Stroke Certification From Joint Commission
The hospital achieved this recognition by meeting rigorous standards for performing endovascular thrombectomy and demonstrating continuous compliance with its performance standards.
Mount Sinai Study Identifies Significant Inequalities Among Low-Risk Births, Finds Higher Rates of Unexpected Complications for Black and Hispanic Infants
Hospital quality of care during delivery is a major factor for racial and ethnic disparities among low-risk newborns
Mount Sinai Announces Landmark Gift from James S. and Merryl H. Tisch to Transform Cancer Care in New York
The Mount Sinai Health System announced today a game-changing $60 million gift from James S. and Merryl H. Tisch to establish the Mount Sinai Tisch Cancer Center.
First of its kind study using multi-omics approach identifies large list of candidate genes associated with alcohol use disorder
New York, NY (Aug 20, 2021) – Researchers from the Icahn School of Medicine at Mount Sinai have published the first study of its kind in the field of addiction genetics using a multi-omics approach to provide a large list…
Mount Sinai Heart Earns Two Prestigious Recognitions for Heart Failure and Catherization Lab
Awards highlight highest level of quality of care
Mount Sinai Mandates COVID-19 Vaccination for All Faculty and Staff
Mount Sinai Health System today announced that all faculty and staff will be required to get the first shot of the vaccine by September 13.
Mount Sinai Mandates COVID-19 Vaccination for All Faculty and Staff
Mount Sinai Health System today announced that all faculty and staff will be required to get the first shot of the vaccine by September 13.
Mount Sinai Receives NCI Grant to Study Anal Cancer Screening in High-Risk Women
The Icahn School of Medicine at Mount Sinai has been awarded a grant of more than $4 million by the National Cancer Institute for a large-scale study to evaluate anal cancer screening in high-risk women who have been previously diagnosed with human papillomavirus (HPV) infection.
Mount Sinai Health System Launches Bold $2 Billion Capital Campaign
Expanding upon its nearly 170-year history of innovation and discovery, the Mount Sinai Health System has launched a bold capital campaign to raise $2 billion by 2025 that will power the organization into a forward-looking era of advanced patient care, research, and education.
Mount Sinai Mobile Interventional Stroke Team Travels to Patients, Resulting in Faster Treatment and Better Outcomes
Study finds stroke patients are nearly twice as likely to be functionally independent if treated by a specialized team that travels to them to perform surgical clot removal
Study Shows Visual Evoked Potential Is a Promising Tool for Translational Research Into Phelan-McDermid Syndrome and Autism Spectrum Disorders
Researchers at the Seaver Autism Center for Research and Treatment at Mount Sinai have identified specific transient visual evoked potential waveform abnormalities in individuals with Phelan-McDermid syndrome (PMS), proving the method to be an effective, noninvasive technique to gather objective data from a range of individuals, including those who are profoundly affected.
Mount Sinai’s J Mocco, MD, to Lead the Society of NeuroInterventional Surgery
J Mocco, MD, MS, Senior Vice Chair, Director of the Cerebrovascular Center, and Co-Director of the Neuroendovascular Surgery Fellowship Program in the Department of Neurosurgery at Mount Sinai, has been named president-elect of the Society of NeuroInterventional Surgery (SNIS), a scientific and educational association dedicated to advancing the specialty of neurointerventional surgery, effective July 29, 2021.
The Mount Sinai Hospital’s Department of Geriatrics Remains No. 1 in U.S. News & World Report Specialty Rankings for Second Year
The Mount Sinai Hospital’s Department of Geriatrics was ranked No. 1 in the nation by U.S. News & World Report for the second consecutive year. The Mount Sinai Hospital was also listed on the “Honor Roll” of the nation’s top 20 hospitals for the sixth year in a row.
Mount Sinai scientists discover early signs of frontotemporal dementia in personalized cerebral organoids
Frontotemporal dementias are a group of fatal and debilitating brain disorders for which there are no cures. In an article published July 26 in Cell, Mount Sinai researchers describe how they were able to recreate much of the damage seen in a widely studied form of the disease by growing special types of cerebral organoids in petri dishes.
The Steven & Alexandra Cohen Foundation Grants More than $2.1 Million to Support a Psychedelics Research Study at Mount Sinai
The Center for Psychedelic Psychotherapy and Trauma Research in the Department of Psychiatry at Mount Sinai today announced a $2.1 million charitable contribution by the Steven & Alexandra Cohen Foundation.
Mount Sinai’s Kalmon D. Post, MD, to Lead The Pituitary Society
Kalmon D. Post, MD, Surgical Co-Director of the Pituitary Care and Research Center, and Chair Emeritus of the Department of Neurosurgery, the Faculty Practice Associates, and The Medical Board at Mount Sinai, has been named president-elect of The Pituitary Society, effective Thursday, July 1
Mount Sinai Recruits Internationally Recognized Cardiovascular Immunology Researcher
Filip Swirski, PhD, named Director of Mount Sinai’s new Cardiovascular Research Institute
Mount Sinai Named Official Medical Service Provider for USA Fencing Team
Department of Rehabilitation and Human Performance prepares athletes for Tokyo Olympic Games
Mount Sinai Research Reveals How the Ebola Virus Manages to Evade the Body’s Immune Defenses
Mount Sinai researchers have uncovered the complex cellular mechanisms of Ebola virus, which could help explain its severe toll on humans and identify potential pathways to treatment and prevention. In a study published in mBio, the team reported how a protein of the Ebola virus, VP24, interacts with the double-layered membrane of the cell nucleus (known as the nuclear envelope), leading to significant damage to cells along with virus replication and the propagation of disease.
Mount Sinai Welcomes Robotic Prostate Surgery Pioneer Mani Menon, MD
Robotic prostate surgery pioneer Mani Menon, MD, is joining Mount Sinai and will serve as Chief of Strategy and Innovation in the Department of Urology for the Mount Sinai Health System. He will also serve as a Professor of Urology, Director of Education and Director of the Precision Prostatectomy Program in the Department of Urology at Icahn Mount Sinai and Center of Excellence for Prostate Cancer at The Tisch Cancer Institute.